Literature DB >> 9572654

Relative survival of cancer patients--a comparison between Denmark and the other Nordic countries.

A Engeland1, T Haldorsen, P W Dickman, T Hakulinen, T R Möller, H H Storm, H Tulinius.   

Abstract

The results of a Nordic collaborative project revealed that Danish cancer patients had a poorer prognosis than patients in the other Nordic countries for some major cancer sites. The present study was undertaken to further explore the differences in survival between Denmark and the other Nordic countries. All cancer cases diagnosed in the Nordic countries during 1958 to 1991/92 were included in the analysis. Relative survival and excess mortality were calculated for intervals in the first five years after diagnosis. Since the 1950s, the prognosis of cancer patients has improved in all the countries, but more moderately in Denmark. For cancers of the stomach, colon, rectum, breast (female), and prostate, the Danish patients had a markedly lower relative survival than the patients in the other countries. They also had the lowest proportion of localized tumours. It appears that Danish cancer patients are diagnosed at a later stage of disease than patients in the other Nordic countries.

Entities:  

Mesh:

Year:  1998        PMID: 9572654     DOI: 10.1080/028418698423177

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  7 in total

1.  The National Bowel Cancer Audit Project: what do trusts think of the National Bowel Cancer Audit and how can it be improved?

Authors:  J A Cornish; H S Tilney; E Tan; M R Thompson; J J Smith; P P Tekkis
Journal:  Tech Coloproctol       Date:  2011-02-02       Impact factor: 3.781

2.  Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

Authors:  Claudia Allemani; Tomohiro Matsuda; Veronica Di Carlo; Rhea Harewood; Melissa Matz; Maja Nikšić; Audrey Bonaventure; Mikhail Valkov; Christopher J Johnson; Jacques Estève; Olufemi J Ogunbiyi; Gulnar Azevedo E Silva; Wan-Qing Chen; Sultan Eser; Gerda Engholm; Charles A Stiller; Alain Monnereau; Ryan R Woods; Otto Visser; Gek Hsiang Lim; Joanne Aitken; Hannah K Weir; Michel P Coleman
Journal:  Lancet       Date:  2018-01-31       Impact factor: 79.321

3.  Survival of patients with kidney cancer in central and northern Denmark, 1998-2009.

Authors:  Tau Pelant; Erik Højkjær Larsen; Lars Lund; Michael Borre; Rune Erichsen; Mette Nørgaard; Jacob Bonde Jacobsen
Journal:  Clin Epidemiol       Date:  2011-07-21       Impact factor: 4.790

4.  Opinion: why the variation in breast cancer survival in Europe?

Authors:  M P Coleman
Journal:  Breast Cancer Res       Date:  1999-10-07       Impact factor: 6.466

5.  Secondary care intervals before and after the introduction of urgent referral guidelines for suspected cancer in Denmark: a comparative before-after study.

Authors:  Mette Bach Larsen; Rikke Pilegaard Hansen; Dorte Gilså Hansen; Frede Olesen; Peter Vedsted
Journal:  BMC Health Serv Res       Date:  2013-09-10       Impact factor: 2.655

6.  Understanding Differences in Cancer Survival between Populations: A New Approach and Application to Breast Cancer Survival Differentials between Danish Regions.

Authors:  Marie-Pier Bergeron-Boucher; Jim Oeppen; Niels Vilstrup Holm; Hanne Melgaard Nielsen; Rune Lindahl-Jacobsen; Maarten Jan Wensink
Journal:  Int J Environ Res Public Health       Date:  2019-08-26       Impact factor: 3.390

7.  A visual summary of the EUROCARE-4 results: a UK perspective.

Authors:  H Møller; K M Linklater; D Robinson
Journal:  Br J Cancer       Date:  2009-12-03       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.